• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Enlightify Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits

    9/2/25 5:10:26 PM ET
    $ENFY
    Agricultural Chemicals
    Industrials
    Get the next $ENFY alert in real time by email
    false 0000857949 CN 0000857949 2025-08-27 2025-08-27 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    FORM 8-K

     

    CURRENT REPORT

     

    Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

     

    Date of Report (Date of earliest event reported): August 27, 2025

     

    Enlightify Inc.

    (Exact name of Registrant as specified in charter)

     

    Nevada   001-34260   36-3526027
    (State or other jurisdiction   (Commission File No.)   (IRS Employer
    of Incorporation)       Identification No.)

     

    3rd Floor, Borough A, Block A.

    No.181 South Taibai Road

    Xi’an, Shaanxi Province

    People’s Republic of China 710065

    (Address of principal executive offices) (Zip Code)

     

    Registrant’s telephone number, including area code: +86-29-88266368

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

     

    ☐ Written communications pursuant to Rule 425 under the Securities Act (17CFR230.425)

     

    ☐ Soliciting material pursuant to Rule14a-12 under the Exchange Act (17CFR240.14a-12)

     

    ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17CFR240.14d-2(b))

     

    ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17CFR240.13e-4(c))

     

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

     

    Emerging growth company ☐

     

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

     

    Securities registered pursuant to Section 12(b) of the Act:

     

    Title of each class   Trading Symbol(s)   Name of each exchange on which
    registered
    Common Stock   ENFY   NYSE

     

     

     

     

    Item 3.01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.

     

    On August 27, 2025, the New York Stock Exchange (“NYSE”) notified Enlightify Inc. (the “Company”) that the 30-trading-day average closing price of the Company’s common stock had fallen below $1.00 per share, the minimum average share price required for continued listing of the Company’s common stock on the NYSE under Rule 802.01C of the NYSE Listed Company Manual.

     

    Under NYSE rules, the Company has 10 business days from its receipt of the notification to inform the NYSE of its intent to cure the share price deficiency to return to compliance with this continued listing standard.  

     

    In order to return to compliance with this continued listing standard, the ending and 30-trading-day average share price of the Company’s common stock must equal or exceed $1.00 on February 27, 2026 (six months from the Company’s receipt of the notification, unless extended) or on the last trading day of any month prior to that date.  No later than September 11, 2025, the Company will notify the NYSE of its intent to cure the share price deficiency and regain compliance with this continued listing standard.

     

    On September 2, 2025, as required by NYSE rules, the Company issued a press release announcing that it had received the notification of non-compliance.  A copy of this press release is attached as Exhibit 99.1 to this Form 8-K.

     

    Item 9.01. Financial Statements and Exhibits.

     

    (d) Exhibits.

     

    Exhibit No.   Description
    99.1   Press Release dated September 2, 2025
    104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

     

    1

     

    SIGNATURES

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     

    Date: September 2, 2025 ENLIGHTIFY INC.
      (Registrant)
         
      By:  /s/ Zhuoyu Li
        Zhuoyu Li
        Chairman of the Board of Directors,
    Chief Executive Officer, and President

     

    2

     

    Get the next $ENFY alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ENFY

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $ENFY
    SEC Filings

    View All

    SEC Form NT 10-Q filed by Enlightify Inc.

    NT 10-Q - Enlightify Inc. (0000857949) (Filer)

    2/18/26 8:14:00 AM ET
    $ENFY
    Agricultural Chemicals
    Industrials

    Enlightify Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

    8-K - Enlightify Inc. (0000857949) (Filer)

    1/9/26 5:00:45 PM ET
    $ENFY
    Agricultural Chemicals
    Industrials

    SEC Form DEF 14A filed by Enlightify Inc.

    DEF 14A - Enlightify Inc. (0000857949) (Filer)

    11/21/25 5:00:43 PM ET
    $ENFY
    Agricultural Chemicals
    Industrials

    $ENFY
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Enlightify Inc. Announces Delisting From NYSE

    XI'AN, CHINA, Oct. 27, 2025 (GLOBE NEWSWIRE) -- Enlightify Inc. (NYSE:ENFY) ("Enlightify" or the "Company"), today announced that it has received notification from the New York Stock Exchange ("NYSE") on October 13, 2025, that the NYSE has determined to commence proceedings to delist the Company's common stock from the exchange. The NYSE determined that the Company was no longer in compliance with the continued listing standard set forth in Section 802.01B of the NYSE Listed Company Manual, which requires listed companies to maintain an average global market capitalization average global market capitalization over a consecutive 30 trading day period of at least $15,000,000. The Company

    10/27/25 5:00:00 PM ET
    $CGA
    $ENFY
    Agricultural Chemicals
    Industrials

    Enlightify Inc. Notifies New York Stock Exchange of Intent to Cure Price Deficiency

    XI'AN, CHINA, Sept. 10, 2025 (GLOBE NEWSWIRE) -- Enlightify Inc. (NYSE:ENFY) ("Enlightify" or the "Company") has notified the New York Stock Exchange ("NYSE") that it intends to cure the price deficiency that resulted from the fact that the 30-trading-day average closing price per share of the Company's common stock was below $1.00, which is the minimum average share price required for continued listing under NYSE rules. Under NYSE rules, the Company has six months (subject to possible extension) to regain compliance with this continued listing standard and avoid delisting.  The Company's common stock continues to be listed and traded on the NYSE, subject to the Company's compliance wi

    9/10/25 5:00:00 PM ET
    $CGA
    $ENFY
    Agricultural Chemicals
    Industrials

    Enlightify Inc. Receives Continued Listing Standards Notice from the New York Stock Exchange

    XI'AN, CHINA, Sept. 02, 2025 (GLOBE NEWSWIRE) -- On August 27, 2025, Enlightify Inc. (NYSE:ENFY) ("Enlightify" or the "Company") was notified by the New York Stock Exchange ("NYSE") that the 30-trading-day average closing price per share of the Company's common stock was below $1.00, which is the minimum average share price required for continued listing under NYSE rules. As required by NYSE rules, no later than September 11, 2025, the Company will notify the NYSE of its intent to cure the share price deficiency and to return to compliance with this continued listing standard. Under NYSE rules, the Company has six months (subject to possible extension) to regain compliance with this cont

    9/2/25 5:00:00 PM ET
    $CGA
    $ENFY
    Agricultural Chemicals
    Industrials